Health-related quality of life in individuals with syndromic autism spectrum disorders

INTRODUCTION

The diagnosis of autism spectrum disorders (ASDs) has increased dramatically over the past decade[1]. The current U.S. prevalence is 1 in 59 children (1.7%) by the age of 8, with boys diagnosed 4 to 5 times more often than girls[2]. Diagnostic criteria for ASDs have been revised in the most recent Diagnostic and Statistical Manual of Mental Disorders, 5^th Edition (DSM-5)[3]. Autism is diagnosed if the two main criteria are met: persistent deficits in social communication and restrictive or repetitive patterns of behavior. Importantly, two qualifiers must also be present: the onset of symptoms must be early in development and the symptoms, particularly delayed communication, must be greater than expected for impairments in other developmental domains.

Autism spectrum disorders are defined as either syndromic or non-syndromic. Children diagnosed with non-syndromic ASD meet the DSM-5 criteria without other significant somatic or neurologic manifestations. This constitutes the majority of individuals diagnosed with autism. In contrast, syndromic ASDs are diagnosed in individuals meeting DSM-5 criteria but also manifesting somatic symptoms or additional neurologic phenotypes. The somatic symptoms may be facial or other physical dysmorphic features or more complex congenital organ abnormalities. Neurologic diagnoses commonly co-occurring with ASD include intellectual disability and epilepsy[4, 5]. Children with a clinical diagnosis of syndromic autism are more likely to have a genomic abnormality than individuals with non-syndromic ASD[6, 7].

Prolonged and multidimensional clinical issues associated with syndromic ASDs are linked to negative lifelong health and socio-economic impact of the affected child and caregivers[8, 9]. Thus, understanding the Health-Related Quality of Life (HRQoL) in children with syndromic ASD and their caregivers is critical to design clinically effective and economically viable interventions for these children.

Health-related quality of life is a multidimensional concept designed to directly measure an individual’s states related to physical, psychological, and social cognitive aspects of life[10]. Literature on HRQoL in children has identified a lower HRQoL in autism relative to other chronic disorders. However, very few studies have examined the HRQoL in pediatric patients diagnosed with syndromic autism. One such study reported that children with Fragile X Syndrome have significantly impaired health-related quality of life with cognitive function most affected[11]. However, HRQoL for other genetic disorders causing syndromic autism have not been widely reported.

This study aims to evaluate the HRQoL of individuals with three syndromic autism disorders: Rett syndrome (RTT), Phelan-McDermid syndrome (PMD) and SYNGAP1-related Intellectual Disability (SYNGAP1-ID), using the PedsQL 4.0 Inventory (see Appendix for more details of clinical phenotypes associated with each disorder). By combining data from multiple genetic disorders that cause syndromic autism for the first time, we obtain an overview of the impact of syndromic autism on HRQoL. Moreover, we are able to compare HRQoL between each genetically-defined autism and with other chronic childhood illnesses to discover the severe impact of these disorders on the affected children and their families.

METHODS

RESULTS

The PedsQL survey results revealed significant differences in health-related quality of life among the three syndromic autisms in each of the dimensions tested and in the overall score (Table 1 and Figure 1A). RTT girls had the lowest total HQoL score among our syndromic ASDs (M=38.03), followed by SYNGAP1-ID (M=43.51), and PMD (M=46.87). Across dimensions, the greatest impairment in syndromic ASDs was in physical functioning (M=33.55) (Figure 1B). When parsing the data based on genetic diagnosis, the greatest impairment for PMD was social functioning (M=38.45), while the greatest impairment for RTT was physical functioning (M=19.64) (Figure 1C and Table 1).

• Download figure
• Open in new tab

FIGURE 1 PedsQL 4.0 data from Phelan-McDermid syndrome, Rett syndrome, and SYNGAP1-related intellectual disability.

A) Combined total scores for PMD, RTT and SYNGAP1-ID. B) Total score and individual domain scores for combined syndromic autism spectrum disorders. C) Total score and individual domain scores for PMD, RTT and SYNGAP1-ID. ** p<0.01, *** p<0.001 (student’s t-test).

For FQOL (Table 2 and Figure 2), the average scores of FQOL for combined syndromic autism for the family interaction (M=3.75), parenting (M=3.52) and disability-related support (M=3.64) were between satisfied and neither satisfied or dissatisfied. For emotional well-being, the average score for combined syndromic autism was between dissatisfied and neither satisfied or dissatisfied (M=2.79). Finally, for physical/material well-being, the average score for combined syndromic autism was in the satisfied range (M=4.05). Thus, the greatest toll on family quality of life for syndromic autism is on emotional well-being. There were significant differences among the syndromic autisms for parenting and family interaction which were driven by lower scores in the SYNGAP1-ID families. Direct comparison between RTT and PMD families revealed no significant differences for genetically-defined syndromic autisms demonstrating each has a similar impact on family quality of life.

• Download figure
• Open in new tab

FIGURE 2 Beach Center Family Quality of Life Scale domain scores.

We next directly evaluated for differences between PMD and RTT patients in the PedsQL dimensions (Figure 1C). Overall, RTT patients scored worse than PMD across physical and emotional dimensions (p<0.001). However, no significant difference was identified in school or social domains. Thus, these data demonstrate significant differences among syndromic autisms in HRQoL of children.

We next assessed the relationship between each of the PedQL dimensions using correlation analysis and tested for inter-item reliabilities for each factor using Cronbach’s alpha. We found a good level of reliability (Tables 3-5) with physical and emotional functioning scores having the highest reliability. Furthermore, for PMD patients, the highest correlations were between physical and school domains as well as social and school domains. In contrast for RTT patients, the correlations across domains were generally lower compared to PMD patients. The highest correlations for RTT were between the physical and school domains as well as between emotional and school domains. The high correlation between physical and school domains likely reflects difficulty in school participation due to physical impairment in girls with RTT.

We next conducted principal components analyses for children’s PedsQL and caregivers’ FQOL (Table 6) separately by diagnosis and with all diagnoses combined. This analysis indicated that the number of factors for PedsQL and FQOL data matrices could be reduced into four to six factors and the percentage of explained variance was between 55% and 73%. This suggests that these individual dimension scores contain information, which might be truly heterogeneous in its nature for RTT and PMD patients and requires further investigation.

PedsQL 4.0 scores were compiled from published datasets in which similar age of inclusion criteria was implemented. Raw PedsQL 4.0 score data from healthy controls, type 1 (T1D) and type 2 diabetes (T2D)[18], intellectual disability (ID)[19], and idiopathic autism[12] were utilized as comparative assessment metric. For ease of interpretability, our PMD, RTT, and SYNGAP1-ID data were aggregated to create a new syndromic ASD cohort. A comparison of these total PedsQL cumulative scores across published datasets (Figure 3A) revealed highest scores in HRQoL among healthy individuals (M = 87.2), followed by type I diabetes (M = 76.61), type II diabetes (M = 74.36), autism (M = 65.2), ID (M = 56.62), and lowest in our syndromic ASDs (M = 42.80) (p = 0.0004). In comparing each dimension measured by the PedsQL among the chronic childhood disorders, syndromic autism consistently scored lower than other chronic childhood illnesses (Figure 3B).

• Download figure
• Open in new tab

FIGURE 3 PedsQL of syndromic autism compared with other chronic childhood illnesses.

A) Total quality of score and B) Domain scores for PedsQL across chronic childhood disorders.

DISCUSSION

Through a validated and simple to administer survey, we discovered that children with syndromic autism spectrum disorders have significantly lower health-related quality of life compared with their neurotypical peers or children with other chronic health disorders. Among the syndromic autisms surveyed, we found that Rett syndrome had the lowest overall health-related quality of life based upon the total score from the PedsQL 4.0 survey driven primarily by lower physical functioning. Surprisingly, each syndromic autism child had a lower HRQoL scores than a idiopathic, non-syndromic autism child.

When comparing individual domains of the syndromic autism spectrum disorders with previously published data for idiopathic autism, we found similar scores in emotional, social and school performance as possibly expected due to both of these groups having clinical diagnosis of autism. Interestingly, the most significant difference between syndromic and idiopathic autism lies in the physical domain measured by the PedsQL. While this is driven by a significant degree by Rett syndrome, we do see greater reported impairment for Phelan-McDermid syndrome and SYNGAP1-ID in physical functioning compared with idiopathic autism as well.

We also found that ASDs not only affect the individual, but the entire family. Children with an ASD tend to report higher anxiety levels than neurotypical children and exhibit greater prevalence of co-occurring internalizing (depressed mood and anxiety) and externalizing (hyperactivity and aggression) behavior problems[20]. There is an elevated risk for parents (caregivers) of children with an ASD to experience mental health problems, such as stress, anxiety, and depression, compared to parents of children without an ASD or the general population. From clinical and transactional models, we know that there is a continuous reciprocal interaction process between children and caregivers. ASD symptoms, including behavioral dysregulation, contribute to increased stress in the parent (caregiver), which may impact the parents’ QOL and inadvertently alters parenting behaviors in ways that reinforce the child’s behavior problems and ASD symptoms, which can further influence the child’s QOL[20]. By viewing this from a transactional family dynamics perspective, we can see that ASDs not only affect the child but the whole family. Further studies addressing areas of improvement for families of children with syndromic ASDs regarding access to medical care, along with the support received by individuals with ASD may prove effective in addressing FQOL improvement.

Annual medical expenditures for children with ASD are four to six times greater than neurotypical children. It has been reported that the additional mean costs of caring for children diagnosed with ASD, including health care, education, ASD-related therapy, family-coordinated services and caregiver time total $17,081 per year[21]. Applying these estimates to the projected 1.7% of children aged 3 to 17 years with ASD in the U.S. results in a total societal cost of $268 billion as of 2015. The societal cost is forecasted to increase to $461 billion by the year 2025[22]. Similar economic modeling has not been performed for syndromic autisms. Given the greater concerns for health-related quality of life in syndromic autism compared with idiopathic autism, the costs per family associated with caring for children with syndromic autism spectrum disorders is presumptively even greater.

This work will aid in identifying therapeutic endpoints for evaluating treatment and intervention efficacy. This is true of both targeted therapy modalities such as physical, language and occupational therapies as well as therapies specifically targeting core autism symptoms such as Applied Behavior Analysis (ABA). From our data, physical impairments are a significant source of reduced quality of life for children with syndromic autism that is potentially overlooked in routine care. This research provides critical evidence, which might inform policymaking decisions regarding reconsideration of existing interventions aimed at patients with syndromic autism.

In addition to aiding clinicians in referring children with syndromic autism to established therapeutic interventions, this work provides a framework for future clinical trials. Many clinical trials for neurodevelopmental disorders have failed in recent years[23]. One hypothesis regarding these failures is that previous trials have been hampered with clinical endpoints (i.e., measurements of cognition) that are difficult to attain improvement in the limited timeframe of typical clinical trials. Health-related quality of life instruments provide a more holistic measurement of child health for clinical trials, that are arguably more robust than any instrument that measures a single neurodevelopmental variable.

This work has limitations that require future investigation. First, because of the anonymous nature of this study, the genetic diagnoses of participants could not be verified. Second, we focused on three genetic diagnoses that strongly predispose to syndromic autism. Whether this is representative of all syndromic autisms is unclear and warrants further investigation. Third, age was not collected in this online survey and as such could not be evaluated as a variable in the HRQoL scores. Future studies investigating correlation of HRQoL with additional co-variables such as age, congenital malformations, epilepsy and degree of intellectual disability will be informative.